The Utility of Second-Look US to Evaluate Abnormal Molecular Breast Imaging Findings: A Retrospective Study
Journal of Breast Imaging · 2025
DOI: 10.1093/jbi/wbae059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Breast Imaging, 2025. Verfasst von Davis C Teichgraeber und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Imaging, The University of Texas MD Anderson Cancer, Houston, TX, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Ultrasonography, Mammary, Molecular Imaging. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.
Abstract (Originalsprache)
Objective
The purpose of this study was to evaluate the utility of US for identifying and characterizing lesions detected on molecular breast imaging (MBI).
Methods
A retrospective single-institution review was performed of patients with MBI studies with subsequent US for abnormal MBI findings between January 1, 2015, and September 30, 2021. Medical records, imaging, and histopathology were reviewed. The reference standard was histopathology and/or imaging follow-up. Associations among MBI findings, the presence of an US correlate, and histopathology were evaluated by Fisher exact tests.
Results
The 32 lesions detected on MBI in 25 patients were evaluated by US, and 19 lesions had an US correlate (19/32, 59%). Mass uptake was more likely to have an US correlate (11/13, 85%; P = .02) than nonmass uptake (7/19, 37%), and mass uptake was more likely to be malignant (5/13, 38%; P = .01). Of the 13 lesions without an US correlate, 5 were evaluated and subsequently biopsied by MRI (2 high-risk lesions and 3 benign lesions). Follow-up MBIs demonstrated stability/resolution for 5 lesions in 4 patients at 6 months or longer. Three patients had no further imaging.
Conclusion
Mass lesions identified on MBI were more likely to have an US correlate and were more likely to be malignant than nonmass lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Imaging, The University of Texas MD Anderson Cancer, Houston, TX, USA.
- Department of Biostatistics, The University of Texas MD Anderson Cancer, Houston, TX, USA.
ORCID-Profile: Davis C Teichgraeber
Förderung
- NCI NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Teichgraeber, D. C., Bassett, R. L., & Whitman, G. J. (2025). The Utility of Second-Look US to Evaluate Abnormal Molecular Breast Imaging Findings: A Retrospective Study. Journal of Breast Imaging. https://doi.org/10.1093/jbi/wbae059
Vancouver
Teichgraeber DC, Bassett RL, Whitman GJ. The Utility of Second-Look US to Evaluate Abnormal Molecular Breast Imaging Findings: A Retrospective Study. Journal of Breast Imaging. 2025. doi:10.1093/jbi/wbae059
BibTeX
@article{Teichgraeber2025,
author = {Teichgraeber, Davis C and Bassett, Roland L and Whitman, Gary J},
title = {The Utility of Second-Look US to Evaluate Abnormal Molecular Breast Imaging Findings: A Retrospective Study},
journal = {Journal of Breast Imaging},
year = {2025},
doi = {10.1093/jbi/wbae059}
}
EUVIMED